MPT0B640

N/A

Report date: 2024/03/07 13:13:11
NME

Base Information

Drug NameMPT0B640
Drug Alias NameMPT0B640
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJoseah Bio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJ INTS BIO Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours

Other Information

ATC CodeN/A
Related LinksN/A